Historical record - last NADAC effective date: 10/18/2017
Product Information
TOPIRAMATE ER 200 MG CAPSULE is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $16.5710 per EA under NDC 00832107315. Its NADAC has been published 65 times since Aug 17, 2016.
FDA first approved this application on Mar 11, 2014. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832107315
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
10/18/2017
Active Ingredients
TOPIRAMATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA205122FDA Approved
3/11/2014
TE Code
AB2
On Market Since
7/7/2014
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE ER 200 MG CAPSULE has been published 65 times since Aug 17, 2016, and over the history we have for it it has risen 24.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.5710 per EA |
|---|---|
| All-time high | $16.5710 (Nov 8, 2017) |
| All-time low | $13.3242 (Aug 17, 2016) |
| Median price | $13.3242 |
| Average price | $14.0802 |
| Largest weekly change | +9.0% (May 3, 2017) |
| Weeks tracked | 65 |
| Tracking since | Aug 17, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+24.4%
Last surveyed Nov 8, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOPIRAMATE ER 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 200 MG CAPSULE, manufactured by Upsher-Smith Laboratories LLC, is $16.5710 per EA (NDC 00832107315), effective Nov 8, 2017.
How has the price of TOPIRAMATE ER 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE ER 200 MG CAPSULE has risen 24.4%. It has been tracked across 65 weekly CMS publications since Aug 17, 2016.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 200 MG CAPSULE?
Since Aug 17, 2016, the NADAC for TOPIRAMATE ER 200 MG CAPSULE has ranged from a low of $13.3242 (Aug 17, 2016) to a high of $16.5710 (Nov 8, 2017), with a median of $13.3242 per EA.
Are there cheaper alternatives to TOPIRAMATE ER 200 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 200 MG SPRINK CAP, is $9.6713 per EA — about 42% below TOPIRAMATE ER 200 MG CAPSULE.
Who manufactures TOPIRAMATE ER 200 MG CAPSULE?
TOPIRAMATE ER 200 MG CAPSULE (NDC 00832107315) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.